Polyethylene glycol-complexed cationic liposome for enhanced cellular uptake and anticancer activity

International Journal of Pharmaceutics

Volumn 382, Issue 1-2, 2009, Pages 254-261

  Jung, Suk Hyun ^a,b   Jung, Soon Hwa ^a   Seong, Hasoo ^a   Cho, Sun Hang ^a   Jeong, Kyu Sung ^b   Shin, Byung Cheol ^a  

^a Korea Research Institute of Chemical Technology   (South Korea)

^b Yonsei University   (South Korea)

Author keywords

Cationic lipid; Intracellular uptake; Liposome; Polyethylene glycol

Indexed keywords

DOXORUBICIN; LIPOSOME; MACROGOL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; AREA UNDER THE CURVE; ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; CYTOTOXICITY; DRUG BLOOD LEVEL; DRUG EFFICACY; FEMALE; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; HALF LIFE TIME; HUMAN; HUMAN CELL; INTRACELLULAR TRANSPORT; MAXIMUM PLASMA CONCENTRATION; MELANOMA CELL; MOUSE; NONHUMAN; OVARY ADENOCARCINOMA; PARTICLE SIZE; PRIORITY JOURNAL; ZETA POTENTIAL;

ADENOCARCINOMA; ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; BIOLOGICAL TRANSPORT; CELL LINE, TUMOR; CELL SURVIVAL; CHEMISTRY, PHARMACEUTICAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DOXORUBICIN; DRUG CARRIERS; DRUG COMPOUNDING; FEMALE; FLOW CYTOMETRY; HUMANS; INJECTIONS, INTRAVENOUS; LIPOSOMES; MAGNETIC RESONANCE SPECTROSCOPY; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED BALB C; MICROSCOPY, FLUORESCENCE; OVARIAN NEOPLASMS; PARTICLE SIZE; POLYETHYLENE GLYCOLS; RATS; RATS, SPRAGUE-DAWLEY; TECHNOLOGY, PHARMACEUTICAL; TIME FACTORS; TUMOR BURDEN; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 70350198034     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2009.08.002     Document Type: Article

References (27)

1. Andresen T.L., Jensen S.S., and Jorgensen K. Advanced strategies in liposomal cancer therapy: problems and prospects of active and tumor specific drug release. Prog. Lipid Res. 44 (2005) 68-97
2. Bajoria R., and Sooranna S.R. Liposome as a drug carrier system: prospects for safer prescribing during pregnancy. Trophoblast. Res. 12 (1998) 265-287
3. Carmona-Ribeiro A.M., Ortis F., Schumacher R.I., and Armelin M.C.S. Interactions between cationic vesicles and cultured mammalian cells. Langmuir 13 (1997) 2215-2218
4. Carvalho L.A., and Carmona-Ribeiro A.M. Interactions between cationic vesicles and serum proteins. Langmuir 14 (1998) 6077-6081
5. ® liposomes: from theory to product. Adv. Drug Deliv. Rev. 24 (1997) 165-177
6. Chandaroy P., Sen A., Alexandridis P., and Hui S.W. Utilizing temperature-sensitive association of Pluronic F-127 with lipid bilayers to control liposome-cell adhesion. Biochim. Biophys. Acta. 1559 (2002) 32-42
7. Dass C.R. Improving anti-angiogenic therapy via selective delivery of cationic liposomes to tumour vasculature. Int. J. Pharm. 267 (2003) 1-12
8. Dhanikula R.S., and Hildgen P. Synthesis and evaluation of novel dendrimers with a hydrophilic interior as nanocarriers for drug delivery. Bioconjug. Chem. 17 (2006) 29-41
9. Drummond D.C., Meyer O., Hong K., Kirpotin D.B., and Papahadjopoulos D. Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors. Pharmacol. Rev. 51 (1999) 691-743
10. Fenske D.B., Palmer L.R., Chen T., Wong K.F., and Cullis P.R. Cationic poly(ethyleneglycol) lipids incorporated into pre-formed vesicles enhance binding and uptake to BHK cells. Biochim. Biophys. Acta 1512 (2001) 259-272
11. Gabizon A., and Papahadjopoulos D. Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors. Proc. Natl. Acad. Sci. 85 (1988) 6949-6953
12. Han H.D., Lee A., Song C.K., Hwang T., Seong H., Lee C.O., and Shin B.C. In vivo distribution and antitumor activity of heparin-stabilized doxorubicin-loaded liposomes. Int. J. Pharm. 313 (2006) 181-188
13. Han H.D., Lee A., Hwang T., Song C.K., Seong H., Hyun J., and Shin B.C. Enhanced circulation time and antitumor activity of doxorubicin by comb like polymer-incorporated liposomes. J. Control. Release 120 (2007) 161-168
14. Hirofumi T., Hiroyuki K., Toshitada T., Hiromitsu Y., Tomoaki H., and Yoshiaki K. Prolonged circulation time of doxorubicin-loaded liposomes coated with a modified polyvinyl alcohol after intravenous injection in rats. Eur. J. Pharm. Biopharm. 48 (1999) 123-129
15. Hwang T., Han H.D., Song C.K., Seong H., Kim J.H., Chen X., and Shin B.C. Anticancer drug-phospholipid conjugate for enhancement of intracellular drug delivery. Macromol. Symp. 249-250 (2007) 109-115
16. Klibanov A.L., Maruyama K., Torchilin V.P., and Huang L. Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes. FEBS Lett. 268 (1990) 235-237
17. Krasnici S., Werner A., Eichhorn M.E., Schmitt-Sody M., Pahernik S.A., Sauer B., Schulze B., Teifel M., Michaelis U., Naujoks K., and Dellian M. Effect of the surface charge of liposomes on their uptake by angiogenic tumor vessels. Int. J. Cancer 105 (2003) 561-567
18. Lv H., Zhang S., Wang B., Cui S., and Yan J. Toxicity of cationic lipids and cationic polymers in gene delivery. J. Control. Release 114 (2006) 100-109
19. Moghimi S.M., and Patel H.M. Serum-mediated recognition of liposomes by phagocytic cells of the reticuloendothelial system: the concept of tissue specificity. Adv. Drug. Deliv. Rev. 32 (1998) 45-60
20. Moghimi S.M., and Szebeni J. Stealth liposomes and long circulating nanoparticle: critical issues in pharmacokinetics, opsonization and protein-binding properties. Prog. Lipid Res. 42 (2003) 463-478
21. Nakazono M., Ma L., and Zaitsu K. Synthesis of poly (3,4,5-trihydroxybenzoate ester) dendrimers and their chemiluminescene. Tetrahedron Lett. 43 (2002) 8185-8189
22. Romoren K., Thu B.J., Bols N.C., and Evensen O. Transfection efficiency and cytotoxicity of cationic liposomes in salmonid cell lines of hepatocyte and macrophage origin. Biochim. Biophys. Acta 1663 (2004) 127-134
23. Sharma A., and Sharma U.S. Liposomes in drug delivery: progress and limitations. Int. J. Pharm. 154 (1997) 123-140
24. Shimada K., Matsuo S., Sadzuka Y., Miyagishima A., Nozawa Y., Hirota S., and Sonobe T. Determination of incorporated amounts of poly(ethyleneglycol)-derivatized lipids in liposomes for the physicochemical characterization of stealth liposomes. Int. J. Pharm. 203 (2000) 255-263
25. Torchilin V.P., and Trubetskoy V.S. Which polymers can make nanoparticulate drug carriers long-circulating?. Adv. Drug. Deliv. Rev. 16 (1995) 141-155
26. Wu J., Lee A., Lu Y., and Lee R.J. Vascular targeting of doxorubicin using cationic liposomes. Int. J. Pharm. 337 (2007) 329-335
27. Xiong X.B., Huang Y., Lu W., Zhang X., Zhang H., Nagai T., and Zhang Q. Enhanced intracellular delivery and improved antitumor efficacy of doxorubicin by sterically stabilized liposomes modified with a synthetic RGD mimetic. J. Control. Release 107 (2005) 262-275